From Medscape HIV/AIDS

Coverage from the

Conference on Retroviruses and Opportunistic Infections (CROI) 2023 Annual Meeting

February 19 - 22, 2023; Seattle, Washington

February 19 - 22, 2023 Seattle, Washington
  • CROI 2023 Long-Acting ART Effective Without Viral Suppression The latest research on long-acting ART shows benefits even among the unsuppressed; meanwhile, early proof-of-concept results on a twice-yearly injection raise hopes.
  • CROI 2023 Meningococcal Vaccine Shows Benefit in STI Prevention A new trial looks at the effect of doxycycline post-exposure prophylaxis and vaccination with meningococcal B vaccine on rates of sexually transmitted infections in men who have sex with men.
  • CROI 2023 8-Week TB Treatment Strategy Shows Potential Although some call the strategy's failure rate 'too high,' it pushes the field a step closer to the 'holy grail' of a short alternative to the standard 24-week regimen.

Conference News

Medscape HIV/AIDS© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from 2022

Previous Coverage